McMaster University

McMaster University

Faculty of
Health Sciences

GlaxoSmithKline

GlaxoSmithKline

A leading research-based pharmaceutical and health care company, GlaxoSmithKline has demonstrated its commitment to improving the quality of human life through its substantial contributions to two endowed chairs at McMaster University.

The company contributed $500,000 in 1998 to help fund the GlaxoSmithKline Chair in Gastroenterology, and has provided an additional $1 million for the McMaster University/GlaxoSmithKline Chair in Lung Immunology, which will operate through the Firestone Institute for Respiratory Health at St. Joseph’s.

As one of the largest research and development organizations in Canada, GlaxoSmithKline invests in pioneering research, such as that carried out at McMaster, as a way to encourage scientists in their important discoveries. The company has about 3,300 employees in Canada and contributes more than $176 million annually to research and development in Canada.

The Chair in Gastroenterology has further strengthened the Faculty of Health Sciences’ research team that investigates gastrointestinal diseases, and the Chair in Respirology will improve the understanding and lead to new treatments for children with asthma.

Paul Lucas, president and CEO of GlaxoSmithKline Inc., said these investments are part of the firm's longstanding commitment to research.

[BACK]

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0